Randomized Phase 2 Study of Atezolizumab and Entinostat in Patients With aTN Breast Cancer With Phase 1b Lead In
Status:
Unknown status
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and tolerability of entinostat used in
combination with atezolizumab in patients with Advanced Triple Negative Breast Cancer
(aTNBC). Additionally the purpose of the study is to assess how effective entinostat and
atezolizumab are in combination in patients with aTNBC.